Orbit Genomics, Inc.
Genomic diagnostic test for lung cancer subtyping and malignancy classification
- Sector
- Medtech
- Headquarters
- CO
- Latest Form D
- $530K, Mar 2025
- Total capital
- $2.5M
- Federal grants
- $2M
- 2 awards · 2024–2025
- Rank in peer group#13 of 79
- Private capital raised
- $530K
- 1 Form D · last Mar 2025
- 19 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 2 pending · first 2025
- Rank in peer group#19 of 79
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of a lung cancer subtyping diagnostic$1.0M
- Private capital raisedForm D · SEC · 1st filing$530K
- Federal grantHealth and Human S · Phase II · Development of a lung cancer subtyping diagnostic$1.0M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
6months
from Orbit Genomics, Inc.’s first federal award to its first private round.
- First federal award · Sep 2024
- Health and Human S · $1.0M
- First Form D · Mar 2025
- $530K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 79 peers
Line = medianMedtech · Instrument
- Federal grants#13 · top 16%
- Granted patents#19 · top 24%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Elizabeth (Dede) N WillisExecutive Officer, DirectorNamed in SEC Form D filings
- Elizabeth (Dede) N WillisExecutive Officer, DirectorNamed in SEC Form D filings
- Harold (Skip) N GarnerExecutive Officer, DirectorNamed in SEC Form D filings
- Julie SilberDirectorNamed in SEC Form D filings
- Oerum N MikaelDirectorNamed in SEC Form D filings
- Randy N BerholtzExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 3- GrantedMethods And Systems For Microsatellite AnalysisUSPTOUS 12,431,220
- PendingMethods And Systems For Microsatellite AnalysisUSPTOApplication PCTUS2020029145
- PendingMethods For Microsatellite AnalysisUSPTOApplication 62837109
Related companies, and why
- KULEANA TECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- FREEFLOW MEDICAL DEVICES LLCSimilar federal contract value in Medtech · null in contracts
- InterShunt Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- Variantyx Inc.Similar federal contract value in Medtech · null in contracts
- Clairity, Inc.Similar federal contract value in Medtech · null in contracts
- GENOMIC LIFE, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .